White paperPublished 2026-10-10
GLP-1 Digital Care and Companion Platforms: What Drives Results—and Why Patients Discontinue
Summary: In this white paper, we examine what helps people achieve lasting results with GLP-1-based treatments and why many discontinue. We explore how medication access, affordability, side effects, clinical follow-up, and everyday support shape the treatment journey. We also review evidence linking digital engagement with better weight-loss outcomes, while distinguishing association from causation. We outline how digital care and companion platforms can support continuity through self-monitoring, lifestyle support, and planned follow-up when treatment changes or stops. Within this framework, we describe SALUNOTE’s role as a non-clinical companion for everyday habits and personal records, with medical decisions remaining with each person’s clinician. The evidence reviewed informs this approach; it does not establish clinical outcomes for SALUNOTE itself.
Conclusion:
Digital GLP-1 care can support substantial weight loss, especially among patients who remain engaged and on treatment. But the population-level value of these services is constrained by low persistence and by barriers that extend beyond software. The evidence favors comprehensive programs that combine medication management with self-monitoring, coaching, personalized feedback, safety escalation, and multidisciplinary follow-up. It also argues for more transparent reporting. Weight loss among completers should always be presented alongside retention, medication persistence, discontinuation reasons, and post-treatment outcomes. The future of GLP-1 digital care will not be determined by which platform generates the most notifications. It will be determined by which platforms help the greatest number of appropriate patients navigate treatment safely, sustain benefit, and receive continuous support when circumstances change. SALUNOTE's contribution to that future is deliberately bounded: a calm, bilingual companion for diet, movement, habits, and self-recorded progress, with medication and medical judgment left to the patient's own clinician. Readers can explore the current product at salunote.com.
For general information only, not medical advice. For anything about your own treatment, ask your doctor.